Trial intelligence / Profile preview

Nexavar and Avastin in Metastatic Colorectal Cancer

NCT00826540Phase 2Completed

Sponsor
Cancer and Leukemia Group B
Start
Sep 2009
Primary completion
Jan 2010
Modality
Small Molecules
Countries
1
01

Overview

A Phase 2 trial of sorafenib in colorectal cancer (CRC), sponsored by Cancer and Leukemia Group B. Started Sep 2009; status: completed.

02

Drugs

sorafenib
03

Conditions

colorectal cancer (CRC)

Beyond the preview

Go deeper on NCT00826540.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00826540.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call